Notice of Intent to issue a Sole Source Award to Procure and Deliver Lateral Flow Test Results from Persons Administered Integrase Inhibitor-based Long-acting Pre-Exposure Prophylaxis (PrEP)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The CDC is seeking to award a sole source contract to the Dallas County Health and Human Services Sexual Health Clinic for the delivery of lateral flow test results from individuals receiving integrase inhibitor-based long-acting pre-exposure prophylaxis (CAB-LA). This clinic is uniquely positioned to meet the requirements due to its established base of over 50 individuals on CAB-LA PrEP for more than six months, a population critical to the study given the low national uptake of this intervention. The clinic serves a demographic with high rates of HIV transmission and sexually transmitted infections, enabling robust participant recruitment and retention across multiple study visits. Its team includes recognized experts in long-acting PrEP care, with a dedicated nurse managing specimen collection, testing logistics, and timely data reporting. The Principal Investigator is integrated into daily patient care operations, ensuring seamless coordination between clinical workflow and research demands. The clinic has proven experience managing IRB-approved protocols and has the infrastructure to collect, process, and ship blood spot specimens to the CDC as required. This contract is part of a CDC effort to evaluate new assays and support surveillance of long-acting PrEP effectiveness. No other provider in the United States currently meets the combined criteria of volume, expertise, clinical integration, and logistical capability required to fulfill these task orders. The notice is not a competitive solicitation, but any responses received by July 23, 2026, will be reviewed by the government to determine whether a competitive procurement is warranted. The award is expected to be issued exclusively to Dallas County Health and Human Services based on its singular capacity. All responses must be submitted electronically to zvm0@cdc.gov, and the place of performance is designated as Dallas, Texas, with the contract managed by the CDC’s Office of Acquisition Services in Atlanta, Georgia.
General Info
Agency
NAICS
Place of Performance
Dallas, TX, 75207, USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
The Centers for Disease Control and Prevention (CDC), Division of HIV Prevention requires
an HIV care clinic within a public health network with a clientele of at least 50 persons on injectable cabotegravir long-acting (CAB-LA) (Apretude) pre-exposure prophylaxis (PrEP) for over 6 months. CAB-LA uptake is very low in the United States therefore having a sufficient number of participants on CAB-LA in one clinic to be able to successfully recruit at least 50 participants combined with serving a population with high transmission rates is key. The Dallas County Health and Human Services Sexual Health Clinic has a team of care providers and recognized leaders in HIV preventative care who can support investigation of new CDC-developed assays and manage requested blood spot specimen collection during care visits. This public health clinic incorporates the second-highest rate of sexually transmitted infection in the country with a high-frequency interaction with clientele to be able to recruit participant numbers and achieve the multiple-visit series of test evaluations within the contract period. No other provider has the combined capacity of recruiting persons with HIV or at increased risk of acquiring HIV, together with the high level of recognized expertise in long-acting PrEP care, and with experience in running Institutional Review Board (IRB)-approved protocols. The Dallas County Health Principal Investigaor (PI) is embedded in the patient care workflow to be able to effectively oversee recruiting and testing logistics. The Dallas County Health clinicians and care providers interact closely to manage the study aims, and they have available a nurse dedicated to ensuring evaluation testing and results upload for timely reporting and shipping of specimen to CDC. Dallas County health has th capability of successfully performing these clinical studies to satisfy CDC task orders and is currently the only identified source currently able to provide the required services to the CDC.This notice of intent is not a request for competitive quotations; however, all Quotations/ responses received within 15 days of the issuance of this notice shall be considered by the government. A determination by the government not to complete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to the contract specialist at email zvm0@cdc.gov by 07/23/2026.